P1051 (10109): A Multiple-Dose, Open-Label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination with Low Dose Ritonavir in HIV-Infected Pediatric Patients

Study Status Study Restriction

Participants Off Study and Primary Analysis Completed

United States

Concluded

United States

Sites where the study was implemented:

CRS ID Site Name City Country
No sites at this time.

Study contacts:

CTS: IMPAACT Operations Center

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.